Danaher Corporation Recognized as Key Player in Growing 3D Cell Culture Market

3D Cell Culture Market Size Expected to Reach USD 7.02

A recent study by Towards Healthcare predicts the 3D cell culture market will grow significantly, reaching approximately USD 6.29 billion by 2033. Danaher Corporation, alongside Thermo Fisher Scientific Inc., is highlighted as a key player in this expanding market, which is driven by technological innovations and a focus on healthcare quality. The report indicates that North America currently leads the market, while Asia Pacific is expected to experience the fastest growth due to increased healthcare sector expansion and demand for new drug discovery solutions.

Danaher Corporation

Danaher Corporation is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. The company designs, manufactures, and markets medical, industrial, and commercial products and services. It operates in the biotechnology, diagnostics, and life sciences sectors.

Cepheid

Pall Corporation

HemoCue AB

IDBS

SCIEX

Leica Microsystems

Integrated DNA Technologies

Beckman Coulter Life Sciences

Aldevron

Cytiva

Phenomenex

abcam

Mammotome

Molecular Devices

Radiometer

Beckman Coulter Diagnostics

Leica Biosystems

Danaher Life Sciences

Beckman Coulter Dx Eastern Europe

Danaher Diagnostics

Danaher India Development Center

Beckman Coulter Diagnostics Europe

Beckman Coulter Dx Turkey

Beckman Coulter Dx India & SWA

Beckman Coulter Dx China

Danaher is a leading global life sciences and diagnostics innovator, committed to accelerating the power of science and technology to improve human health. We partner with customers across the globe to help them solve their most complex challenges, architecting solutions that bring the power of science to life. Our global teams are pioneering what’s next across Life Sciences, Diagnostics, Biotechnology and beyond. For more information, visit www.danaher.com.

Atlantis Components

Today we shared results for the fourth quarter and full year 2023. See the release: https://bit.ly/3Sl5JAv

We couldn’t agree more with this passionate piece from our collaborator Jennifer Doudna and the Innovative Genomics Institute. This is just the beginning. https://lnkd.in/dNhzbNKd

Our Beacons program, launched in 2022, invests in pioneering academic research to develop innovative technologies and applications for human health. See the Beacons focus areas, current partnerships and potential impact: https://bit.ly/3U9t1vK

Big congratulations to the Danaher China team for being recognized as a Top Employer in China for the third consecutive year, a reflection of their commitment to excellence in people practices and continuous improvement.  #bestteamwins

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, particle counting and characterization; microscopes; genomics consumables; and Gene and Cell Therapy. This segment also offers bioprocess technologies, consumables, and services; and filtration, separation, and purification technologies to the pharmaceutical and biopharmaceutical, food and beverage, medical, and life sciences companies, as well as universities, medical schools and research institutions, and various industrial manufacturers. The Diagnostics segment provides chemistry, immunoassay, microbiology, and automation systems, as well as hematology, molecular, acute care, and pathology diagnostics products. This segment offers clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The Environmental & Applied Solutions segment offers instrumentation, consumables, software, services, and disinfection systems to analyze, treat, and manage ultra-pure, potable, industrial, waste, ground, source, and ocean water in residential, commercial, industrial, and natural resource applications. This segment also provides instruments, software, services, and consumables for various color and appearance management, packaging design and quality management, packaging converting, printing, marking, coding, and traceability applications for consumer, pharmaceutical, and industrial products. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is headquartered in Washington, the District of Columbia.

COM:DANAHER

Danaher Corporation

Last Close

233.10

21/11 20:59

Market Cap

179.39B

Beta: -

Volume Today

2.17M

Avg: -

Analysis Not Available